Reasons for non-participation in an international multicenter trial of a new drug for tuberculosis treatment

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 4, 2012, Pages 480-485

  Lamunu, Dorcas ^a   Chapman, K N ^b   Nsubuga, P ^a   Muzanyi, G ^a   Mulumba, Y ^a   Mugerwa, M A ^a   Goldberg, S ^b   Bozeman, L ^b   Engle, M ^c,d   Saukkonen, J ^e   Mastranunzio, S ^a   Mayanja Kizza, H ^a,f   Johnson, J L ^a,g,h  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f MAKERERE UNIVERSITY   (Uganda)

^g CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Anti tuberculosis agents; Clinical trial; Moxifloxacin; Non participation; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; MOXIFLOXACIN; PYRAZINAMIDE; RIFAMPICIN;

ADOLESCENT; ADULT; AFRICA; AGED; ARTICLE; CHILD; CLINICAL PROTOCOL; CLINICAL RESEARCH; CONFLICT OF INTEREST; CONTROLLED STUDY; DEMOGRAPHY; DRUG EFFICACY; DRUG SAFETY; EUROPE; FAMILY; FEMALE; GEOGRAPHY; HUMAN; LIFESTYLE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICAL STAFF; MULTICENTER STUDY; NORTH AMERICA; PATIENT PARTICIPATION; PERSONAL EXPERIENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SOCIOECONOMICS; SOUTH AMERICA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; CHILD; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; PROSPECTIVE STUDIES; REFUSAL TO PARTICIPATE; TUBERCULOSIS; YOUNG ADULT;

EID: 84863365887     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0434     Document Type: Article

References (17)

1. Schulz K F, Altman D G, Moher D, for the CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med 2010; 152: 726-732.
2. Gul R B, Ali P A. Clinical trials: the challenge of recruitment and retention of participants. J Clin Nurs 2010; 19: 227-233.
3. Dorman S E, Johnson J L, Goldberg S, et al. Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis. Am J Respir Crit Care Med 2009; 180: 273-280.
4. World Health Organization. WHO regional offices. Geneva, Switzerland: WHO, 2011. http://www.who.int/about/regions/en/index.html Accessed January 2012.
5. Ellis P M. Attitudes towards and participation in randomised clinical trials in oncology: a review of the literature. Ann Oncol 2000; 11: 939-945.
6. Sen Biswas M, Newby L K, Bastian L A, Peterson E D, Sugarman J. Who refuses enrollment in cardiac clinical trials? Clin Trials 2007; 4: 258-263. (Pubitemid 47407590)
7. Sharp L, Cotton S C, Alexander L, Williams E, Gray N M, Reid J M. Reasons for participation and non-participation in a randomized controlled trial: postal questionnaire surveys of women eligible for TOMBOLA (Trial of Management of Borderline and Other Low-Grade Abnormal Smears). Clin Trials 2006; 3: 431-442.
8. Sood A, Prasad K, Chhatwani L, et al. Patients' attitudes and preferences about participation and recruitment strategies in clinical trials. Mayo Clin Proc 2009; 84: 243-247.
9. Breese P E, Burman W J, Goldberg S, Weis S E. Education level, primary language, and comprehension of the informed consent process. J Empir Res Hum Res Ethics 2007; 2: 69-79.
10. Locock L, Smith L. Personal benefit, or benefiting others? Deciding whether to take part in clinical trials. Clinical Trials 2011; 8: 85-93.
11. McCann S K, Campbell M K, Entwistle V A. Reasons for participating in randomised controlled trials: conditional altruism and considerations for self. Trials 2010; 11: 31.
12. Ross S, Grant A, Counsell C, Gillespie W, Russell I, Prescott R. Barriers to participation in randomised controlled trials: a systematic review. J Clin Epidemiol 1999; 52: 1143-1156. (Pubitemid 29535414)
13. Kironde S, Klaasen S. What motivates lay volunteers in high burden but resource-limited tuberculosis control programmes? Perceptions from the Northern Cape province, South Africa. Int J Tuberc Lung Dis 2002; 6: 104-110. (Pubitemid 34263700)
14. Armstrong B K, White E, Saracci R. Principles of exposure measurement in epidemiology. New York, NY, USA: Oxford University Press, 1995.
15. Edwards P. Questionnaires in clinical trials: guidelines for optimal design and administration. Trials 2010; 11: 2.
16. Crosby R A, DiClemente R J, Salazar L F. Research methods in health promotion. 1st ed. San Francisco, CA, USA: Jossey-Bass, 2006.
17. Garber M C, Nau D P, Erickson S R, Aikens J E, Lawrence J B. The concordance of self-report with other measures of medication adherence: a summary of the literature. Med Care 2004; 42: 649-652.